Jefferies lowered the firm’s price target on Progyny (PGNY) to $19 from $24 and keeps a Buy rating on the shares. The firm is lowering estimates to reflect selling season results – 1.1M member adds offset by about 700,000 from a previously announced customer loss – while also taking “a more conservative approach” to modeling utilization/mix in Q4 and FY25.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on PGNY:
- Progyny price target lowered to $17 from $18 at Canaccord
- Progyny price target lowered to $21 from $22 at BofA
- Progyny downgraded to Hold from Buy at Truist
- Progyny, Inc. Reports Steady Growth Amid Strategic Wins
- Closing Bell Movers: Instacart down 6% after earnings
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
